These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients. Illa I, Rojas R, Gallardo E, Serrano C, Graus F. Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771 [Abstract] [Full Text] [Related]
5. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. Nobile-Orazio E, Giannotta C, Briani C. J Neuroimmunol; 2010 Feb 26; 219(1-2):119-22. PubMed ID: 20006388 [Abstract] [Full Text] [Related]
6. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? Nobile-Orazio E, Gallia F, Terenghi F, Allaria S, Giannotta C, Carpo M. J Neurol Sci; 2008 Mar 15; 266(1-2):156-63. PubMed ID: 17915254 [Abstract] [Full Text] [Related]
7. [A syndrome of chronic ataxic polyneuropathy, ophtalmoplegia, IgM paraprotein, cold agglutinins and anti-disialosyl antibodies can cause diplopia in patients with chronic sensory polyneuropathy]. Kolmos EB, Moth Henriksen M, Abildgaard N, Sindrup SH. Ugeskr Laeger; 2012 Oct 22; 174(43):2635-6. PubMed ID: 23095653 [Abstract] [Full Text] [Related]
8. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G. Ann Neurol; 1996 Apr 22; 39(4):539-43. PubMed ID: 8619533 [Abstract] [Full Text] [Related]
11. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N. J Neuroimmunol; 2006 Aug 22; 177(1-2):201-8. PubMed ID: 16844234 [Abstract] [Full Text] [Related]
12. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. Ortiz N, Rosa R, Gallardo E, Illa I, Tomas J, Aubry J, Sabater M, Santafé M. J Neuroimmunol; 2001 Sep 03; 119(1):114-23. PubMed ID: 11525808 [Abstract] [Full Text] [Related]
14. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD. Cancer Res; 1989 Dec 01; 49(23):6645-51. PubMed ID: 2479468 [Abstract] [Full Text] [Related]
18. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats. Halstead SK, Jackson M, Bianchi E, Rupp S, Granger N, Menchetti M, Galli G, Freeman P, Kaczmarska A, Bhatti SFM, Brocal J, José-López R, Tipold A, Gutierrez Quintana R, Ives EJ, Liatis T, Nessler J, Rusbridge C, Willison HJ, Rupp A. J Peripher Nerv Syst; 2023 Mar 01; 28(1):32-40. PubMed ID: 36573790 [Abstract] [Full Text] [Related]
19. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. Busby M, Donaghy M. J Neurol; 2003 Jun 01; 250(6):714-24. PubMed ID: 12796835 [Abstract] [Full Text] [Related]
20. Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I. J Neuroimmunol; 2001 Feb 15; 113(2):260-7. PubMed ID: 11164910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]